Literature DB >> 19822552

Is there a need to include HIV, HBV and HCV viruses in the Saudi premarital screening program on the basis of their prevalence and transmission risk factors?

F M Alswaidi1, S J O'Brien.   

Abstract

BACKGROUND: In January 2008, the Saudi Arabian health authority included mandatory testing for HIV, HBV and HCV viruses in the premarital screening program. Epidemiologically, there were few justifications for their inclusion as disease prevalences and distributions are poorly understood in the population. This study aims to provide information about HBV, HCV and HIV prevalences and risk factors for disease transmission and so produce evidence for informed decision-making on the inclusion of these infectious diseases in the screening program.
METHODS: This is a cross-sectional descriptive study embedded in the existing national premarital screening program for thalassaemia and sickle cell disease to estimate the prevalence of HIV, HBV and HCV infections (n=74,662 individuals), followed by a case-control study to identify risk factors responsible for infection transmission (n=540).
RESULTS: The average HIV prevalence is 0.03%, 1.31% for HBV and 0.33% for HCV. Sharing personal belongings particularly razors, blood transfusions, cuts at barbershops and extramarital relationships showed the highest significant associations with the transmission of these viruses.
CONCLUSION: The prevalences of HIV, HBV and HCV in Saudi Arabia are among the lowest worldwide. However, all the important risk factors associated with transmitting these viruses are significantly present in the Saudi community. Saudi Arabia is financially capable of screening for these infections in the mandatory premarital program and of providing medical care for the discovered cases, but focusing on the health education programs may offset the need to mandatory testing.

Entities:  

Mesh:

Year:  2009        PMID: 19822552     DOI: 10.1136/jech.2009.093302

Source DB:  PubMed          Journal:  J Epidemiol Community Health        ISSN: 0143-005X            Impact factor:   3.710


  25 in total

1.  Liver transplantation for hepatitis B virus: Decreasing indication and changing trends.

Authors:  Waleed Al-Hamoudi; Hussien Elsiesy; Abdulrahman Bendahmash; Nasser Al-Masri; Safiyya Ali; Naglaa Allam; Mohammed Al Sofayan; Hamad Al Bahili; Mohammed Al Sebayel; Dieter Broering; Sammy Saab; Faisal Abaalkhail
Journal:  World J Gastroenterol       Date:  2015-07-14       Impact factor: 5.742

2.  The impact of metabolic syndrome and prevalent liver disease on living donor liver transplantation: a pressing need to expand the pool.

Authors:  Waleed Al-Hamoudi; Faisal Abaalkhail; Abdurahman Bendahmash; Naglaa Allam; Bassem Hegab; Yasser Elsheikh; Hamad Al-bahili; Nasser Almasri; Mohammed Al-sofayan; Saleh Alabbad; Mohammed Al-Sebayel; Dieter Broering; Hussien Elsiesy
Journal:  Hepatol Int       Date:  2015-09-04       Impact factor: 6.047

Review 3.  SASLT position statement on the direct-acting antiviral agents for the treatment of hepatitis C virus infection.

Authors:  Abdullah S Alghamdi; Adel Alqutub; Faisal Abaalkhail; Faisal M Sanai; Hamdan Alghamdi; Ibrahim Altraif; Khalid A Alswat; Mohammed Y Alghamdi; Mohammed A Babatin; Faleh Z Alfaleh
Journal:  Saudi J Gastroenterol       Date:  2015 Mar-Apr       Impact factor: 2.485

4.  Viral hepatitis in Saudi Arabia. An unfinished story.

Authors:  Ayman A Abdo; Faisal M Sanai
Journal:  Saudi Med J       Date:  2015-07       Impact factor: 1.484

5.  SASLT practice guidelines: management of hepatitis C virus infection.

Authors:  Abdullah S Alghamdi; Faisal M Sanai; Mona Ismail; Hamdan Alghamdi; Khalid Alswat; Adel Alqutub; Ibrahim Altraif; Hemant Shah; Faleh Z Alfaleh
Journal:  Saudi J Gastroenterol       Date:  2012-09       Impact factor: 2.485

Review 6.  Outcomes of hepatitis C screening programs targeted at risk groups hidden in the general population: a systematic review.

Authors:  Freke R Zuure; Anouk T Urbanus; Miranda W Langendam; Charles W Helsper; Charlotte H S B van den Berg; Udi Davidovich; Maria Prins
Journal:  BMC Public Health       Date:  2014-01-22       Impact factor: 3.295

Review 7.  Epidemiology of viral hepatitis in Saudi Arabia: are we off the hook?

Authors:  Ayman A Abdo; Faisal M Sanai; Faleh Z Al-Faleh
Journal:  Saudi J Gastroenterol       Date:  2012 Nov-Dec       Impact factor: 2.485

8.  SASLT practice guidelines for the management of hepatitis B virus.

Authors:  Faisal Abaalkhail; Hussien Elsiesy; Ahmed AlOmair; Mohammed Y Alghamdi; Abduljaleel Alalwan; Nasser AlMasri; Waleed Al-Hamoudi
Journal:  Saudi J Gastroenterol       Date:  2014 Jan-Feb       Impact factor: 2.485

9.  The declining rates of hepatitis B carriage among adolescents and young people in the Eastern region of Saudi Arabia.

Authors:  Khalid M Al-Jubran; Mohamed A Al-Dossary; Salah H Elsafi
Journal:  Saudi Med J       Date:  2016-08       Impact factor: 1.484

Review 10.  The new era of hepatitis C virus therapy.

Authors:  Bandar Al-Judaibi
Journal:  Saudi J Gastroenterol       Date:  2015 Nov-Dec       Impact factor: 2.485

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.